Results 1 to 2 of 2

Thread: Zoetis Inc (NYSE:ZTS)

  1. #1
    Super Moderator
    Join Date
    Apr 2015
    Posts
    2,383

    Zoetis Inc (NYSE:ZTS)

    Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company markets products across four regions: the United States, Europe/Africa/Middle East, Canada/Latin America and Asia/Pacific; eight species: the livestock species of cattle, swine, poultry, sheep and fish, and the companion animal species of dogs, cats and horses, and five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceutical products. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.

    Official website: www.zoetis.com

  2. #2
    A recent analyst activity consisted of Jefferies reiterating their Buy stance on May 21. Jefferies increased their price target on ZTS from $55 to $60. This corresponds to a 25.52% upside from the last closing price. On the date of report, the stock closed at $47.8.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
About us
StockMarketsReview.com provides news coverage, analysis and researches for world stock markets, commodities and currencies. We publish articles provided by experts of leading brokerage and investment companies. At our website investors can find daily, weekly and monthly reports, news, recommendations on the IPOs and fundamental analysis for stocks which are currently traded at the stock exchange.